|
 |
ZydisThis page contains recent news articles, when available, and an overview of Zydis but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Carolyn Logan, President and CEO of Salix, commented that, "Zydis fast dissolve was selected for Metozolv ODT because this innovative formulation of ... Reuters FDA OKs New Salix Product Exclusively in Catalent's Zydis Fast Dissolve Technology - Nov 6, 2009 Carolyn Logan, President and CEO of Salix, said that, "Zydis fast dissolve was selected for Metozolv ODT because this innovative formulation of ... Trading Markets (press release) Drug capsule firm sheds 275 jobs - Nov 9, 2009 The 550 workers at Catalent's Zydis fast-dissolving tablets' factory in Swindon have been told their jobs remain secure. All the affected workers have been ... BBC News Barr withdraws patent suit related to generic Zyprexa - Jun 11, 2007 The unit, Barr Laboratories, said it has changed the application for a generic version of Zyprexa Zydis tablets to a paragraph III certification from a ... Reuters Salix Pharmaceuticals Acquires Patent-Protected Metoclopramide-Zydis(... - Sep 5, 2007 Catalent's Zydis(R) technology is a unique, freeze-dried oral solid dosage form ... We believe the availability of metoclopromide-Zydis(R) should serve to ... Genetic Engineering News - Genetic Engineering News (press release) Valeant Pharmaceuticals (VRX) Announces US Launch of Zelapar - Jul 18, 2006 Zelapar is the first Parkinson's disease treatment to use a novel oral delivery system called Zydis(R) Technology, which allows the tablets to dissolve ... StreetInsider.com - StreetInsider.com (subscription) switch to Zyprexa Zydis - May 30, 2008 Well, I was taken off the Geodon yesterday because it was wreaking havoc on me physically and mentally. I was beginning to have the hallmark signs of a ... HealthCentral.com Fast-dissolving Selegiline (Zelapar Zydis) Reduces "Off-Time" in Up... - Oct 3, 2005 By Paula Moyer. SAN DIEGO, CA -- October 3, 2005 -- The buccally absorbed formulation of selegiline (Zelapar(R)) using the Zydis(R) fast-dissolving ... DG News … : Barr Announces Withdrawal of ZYPREXA(R) Zydis(R) Patent Litigation... - Jun 11, 2007 Barr Announces Withdrawal of ZYPREXA(R) Zydis(R) Patent Litigation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Catalent's deal with ALK-Abello will expand Zydis capacity. - Sep 3, 2007 Catalent's deal with ALK-Abello will expand Zydis capacity. New Jersey, USA-based Catalent Pharma Solutions and Danish pharmaceutical company ALK-Abello A/S ... $9.94 - Pharma Marketletter - Alacra Store Netherlands Corporate News - Catalent Pharma Solutions tekent … - Aug 29, 2007 Zydis, Catalent's fast dissolving oral tablet used in GRAZAX, can be swallowed ... Zydis offers the potential for added patient and consumer convenience, ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Ð’ СШÐ? зарегиÑ?трирован дженерик Zydis® - Nov 15, 2006 КомпаниÑ? Barr Pharmaceuticals, Inc. Ñ?ообщила, что FDA зарегиÑ?трировало препарат Zydis® (Olanzapine) в таблетках по 5, 10, 15 и 20 мг. ... ФармацевтичеÑ?кий веÑ?тник … Approval for a Generic Version of ZYPREXA(R) Zydis(R) Tablets,... - Nov 9, 2006 The patent listed in the Orange Book for ZYPREXA Zydis expires on April 23, 2011. Barr's Abbreviated New Drug Application (ANDA) alleges that the Orange ... Pay-Per-View - PR Newswire - HighBeam Research … Tentative Approval For A Generic Version Of ZYPREXA(R) Zydis(R) … - Nov 13, 2006 The patent listed in the Orange Book for ZYPREXA Zydis expires on April 23, 2011. Barr's Abbreviated New Drug Application (ANDA) alleges that the Orange ... Lifescience-online FINAL TRANSCRIPT - May 13, 2008 Work continues in our Swindon, UK Zydis facility on two new high output ... additional Zydis line in Somerset, New Jersey is now in the validation phase. ... $54.00 - Thomson StreetEvents - Alacra Store Advancing ODT technology: orally disintegrating tablets (ODTs)... - Oct 1, 2007 A commercial Zydis line was installed into a space in existing buildings, ... "The Zydis process involves the preparation of an aqueous solution or ... $9.94 - Pharmaceutical Technology - Alacra Store Patent Victory Gives Lilly Breathing Room | Article from AP Online | ... - Apr 15, 2005 Barr is seeking to sell a generic version of Zyprexa Zydis in the United States. Zydis, a wafer form of the drug, rapidly dissolves on contact with saliva ... Pay-Per-View - AP Online - HighBeam Research EDITED BRIEF - May 6, 2008 11/30/08 PDUFA date for metoclopramide-ZYDIS, licensed from Wilmington ... Granulated mesalamine and metoclopramide-ZYDIS launches in early 2009. ... $54.00 - Thomson StreetEvents - Alacra Store Melt in mouth tablet: An innovative technology for convenience - Nov 29, 2006 Zydis, a freeze dried formulation, was the first marketed new technology tablet ... The MMT industry was historically dominated by the innovator of Zydis. ... pharmabiz.com Barr Laboratories Inc., a subsidiary of Barr Pharmaceuticals, Inc., … - Dec 6, 2007 The patent listed in the Orange Book for ZYPREXA Zydis expires on April 23, 2011 and the associated pediatric exclusivity expires on October 23, 2011. ... ag-IP-news Agency Zyprexa.(Drug overview) - Jan 22, 2007 The drug is available as Zyprexa tablets and Zyprexa Zydis, ... To use Zyprexa Zydis, open the sachet, peel back the foil on the blister pack, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Miller v. BDK, 742 NW2d 41, 2007 ND 186 (ND 12/05/2007) - Dec 5, 2007 The drugs taken on a regular basis include Cogentin, Topiramate, Propranolol, Seroquel, Hydrodiuril, and Zydis. The prn drugs taken to calm BK and stabilize ... $2.95 - North Dakota Supreme Court - VersusLaw Barr Pharma (BRL) Receives Tentative FDA Approval for Generic … - Nov 9, 2006 The patent listed in the Orange Book for ZYPREXA Zydis expires on April 23, 2011. Barr's Abbreviated New Drug Application (ANDA) alleges that the Orange ... StreetInsider.com - StreetInsider.com (subscription) Catalent reshuffles business, reports operating loss - Sep 20, 2007 The firm attributed this increase to the performance of the Packaging Services segment, particularly in Europe, and to the strong demand for its Zydis ... OutSourcing-Pharma.com … acuerdo con ALK-Abello para ampliar capacidad de producción de... - Aug 29, 2007 ...un aumento considerable en la capacidad de producción de Zydis®, unas comprimidos solubles orales para productos inmunoterapéuticos de ALK-Abelló. ... elEconomista.es Article: Prescription anti-anxiety medication is new drug of choice... - Jan 29, 2006 Article: Cardinal Health's Zydis(R) Drug Delivery Technology Used To ... ... "The launch of KLONOPIN WAFERS enhances Zydis' position as the ... ... Pay-Per-View - Deseret News - HighBeam Research Article: Orally disintegrating alprazolam.(FYI)(Brief Article) -... - Apr 1, 2005 Eli Lilly & Co. has launched Zyprexa Zydis (olanzapine orally disintegrating tablets), a new formulation that dissolves in the mouth on contact with saliva. ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Catalent Pharma Solutions Reports Fiscal 2008 First Quarter Results.(... - Nov 13, 2007 The EBITDA for Oral Technologies increased by $7.3 million, primarily due to strong demand for pharmaceutical products and increased throughput of Zydis[R] ... Free with registration - Business Wire - AccessMyLibrary.com Clues to Park's users reside in their refuse - Aug 21, 2008 The icing on the cake is the packet of Zyprexa Zydis (15mg), an anti-psychotic medication used to treat conditions such as schizophrenia and bipolar ... Rocky Mountain News South Dakota Supreme Court Reports - STATE v. CALIN, 2005 SD 13 - Jan 26, 2005 The original antipsychotic medication was ineffective and eventually Calin was put on a high dose of an antipsychotic called Zydis. ... Pay-Per-View - South Dakota Supreme Court Reports - Loislaw Roy v. Commissioner of the Social Security Administration, No. 7:07... - Apr 30, 2008 Her caseworker came to help calm her down, and Dr. Decena increased the dosage of her Zyprexa, and prescribed Zyprexa Zydis at a small dose during the day ... $2.95 - U.S. District Court, Northern District... - VersusLaw The trial that would never come for Rosie Sims: Schizophrenic ran out... - Nov 11, 2006 They switched to Zydis. They added Lithium. They raised the dose. Then raised it some more. Eventually, Rosie's mind responded. And she was returned to the ... Free with registration - Dallas Morning News - AccessMyLibrary.com Sterile manufacturing holds back Cardinal Health in 3Q - May 2, 2005 ...from the launch of branded pharmaceuticals using Cardinal Health's Zydis quick dissolve formulation, as well as ongoing productivity improvements. ... In-PharmaTechnologist.com Lillys Zyprexa LAI trips up over sedation effects - Mar 3, 2008 ...acute agitation associated with schizophrenia and bipolar mania, alongside Zyprexa Tablets and Zyprexa Zydis (olanzapine orally disintegrating tablets). ... In-PharmaTechnologist.com Valeant Pharmaceuticals submits complete response to FDA approvable … - Jan 5, 2005 Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Cardinal Health Announces Plans to Sell $1.8 Billion Pharmaceutical … - Nov 30, 2006 Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, and holds patents for softgel and Zydis(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Netherlands Corporate News - Catalent Pharma Solutions maakt … - May 13, 2008 Oral Technologies' growth was led by Zydis(R), which experienced a nearly 22.5% growth in revenues on a constant dollar basis. ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Q2 2005 Cardinal Health, Inc. Earnings Conference Call - Final. - Feb 4, 2005 Frankly, all of MPS, including its distribution and manufacturing areas; oral technologies, which is our soft gels and Zydis businesses; nuclear pharmacies, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com ADA: Metabolic Monitoring Guidelines for Antipsychotics Largely … - Jun 10, 2008 Her study included 18176 adults initiating aripiprazole (Abilify), clozapine (Clozaril, FazaClo), olanzapine (Zyprexa, Zydis), quetiapine (Seroquel), ... MedPage Today Injection to aid treatment of mental illness - Sep 7, 2005 Last year PHARMAC widened access to the atypical antipsychotic olanzapine and listed dissolvable olanzapine wafers (Zyprexa Zydis). ... scoop.co.nz 新技术掀起医è?¯é?©å‘½æ€§æµªæ½® - Feb 23, 2006 Zydis法与普通的冻干方法，例如粉针冻干工艺ä¸?å?Œï¼Œä¸»è¦?是将主è?¯å’Œè¾…料定é‡?分装在一定 模具ä¸ï¼Œå†»å¹²åŽ»æ°´ï¼Œåˆ¶å¾—高å”隙率的固体制剂。该法为英国RPSchererå…¬å?¸ä¸“利，å?„制è?¯ ... 金èž?ç•Œ Loislaw Federal District Court Opinions - ROY v. COMMISSIONER OF … - Apr 30, 2008 Her caseworker came to help calm her down, and Dr. Decena increased the dosage of her Zyprexa, and prescribed Zyprexa Zydis at a small dose during the day ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Depression, anxiety, and delirium - Jan 1, 2005 Though it is not available for parenteral administration, the Zydis formulation of olanzapine is an orally disintegrating tablet that easily dissolves in ... Psychiatric Times Cardinal Health to Sell Pharmaceutical Technologies and Services … - Jan 25, 2007 Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, and holds patents for softgel and Zydis(R) ... Free with registration - PR Newswire - AccessMyLibrary.com '물없ì?´ 먹는 약' 나왔다 - Mar 30, 2006 ...ìž?ì?´í”„ë ‰ì‚¬ ìž?ì?´ë””스(Zydis)'는 약ì?„ ìž…ì—? 넣으면 소량ì?˜ 침ì—? ì?˜í•´ 녹아 í?¡ìˆ˜ë?œë‹¤. 약 먹기를 꺼리는 ì •ì‹ ì§ˆí™˜ 환ìž?들ì?˜ 약 복용 거부ê°?ì?„ 줄여줘 치료효과를 높ì?¼ ... ì„œìš¸ê²½ì œ Fast Melting Nutritional Supplement Tablets - Dec 23, 2008 H. Seager, "Drug Delivery Products and the Zydis Fast-Dissolving Dosage form," J. Pharm. Pharmacol. 50 (4), 375–382 (1998). G. Carnaby-Mann; M. Crary; ... Alternative Health Journal CRS organises international symposium on NDDS - Jun 2, 2005 He also discussed various technologies for orally disintegrating dosage forms (ODDF) like Durasolv, Flashdose, Oraquick, Advatab, Zydis and the advantages ... expresspharmapulse.com Vakarų ekspresas, Orgazmo Å¡ventÄ— KlaipÄ—doje - tik 2056 metais - Aug 6, 2006 Zuda zmones,vaikus ..koks skirtumas kas tie vaikai vyrai ,musulmonai zydai ar katolikai,paskui zydis mus ,musu vaikus,sakis ,,del viso pikto, ... Vakarų ekspresas Salix Initiates Phase 3 For Rifaximin in Non-Constipation Irritable... - Jul 1, 2008 Vapreotide acetate, metoclopramide-ZYDIS®, balsalazide tablet, granulated mesalamine and rifaximin for additional indications are under development. ... carolinanewswire.com Entacapone (Systemic). - Jul 28, 2005 Apomorphine (eg, Zydis) or Bitolterol (eg, Tornalate) or Epinephrine (eg, Adrenalin) or Isoetherine (eg, Bronkosol) or Isoproterenol (eg, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Salix Pharmaceuticals to Present at Wachovia Conference. - Jan 24, 2008 Current development projects include balsalazide tablet, metoclopramide-Zydis([R]),encapsulated mesalamine granules, vapreotide acetate, and rifaximin for ... Free with registration - Business Wire - AccessMyLibrary.com Schizophrenics On Medication At An Increased Risk For Developing … - Jan 10, 2005 Zydis), or risperidone (Risperdal). The participants followed a certain diet to maintain body weight and fasted before having a glucose tolerance test. ... MedIndia Valeant Gains Clearance For Parkinson's Adjunct, Zelapar - Jun 16, 2006 Zelapar is delivered using the Zydis delivery system, a technology developed by Cardinal Health, which allows the orally disintegrating tablet to "dissolve ... BioWorld Online - BioWorld Online Catalent Pharma Solutions publie ses résultats pour l'exercice 2007 (... - Jun 30, 2007 ...services de conditionnement », particulièrement en Europe, ainsi que de la demande soutenue de nos produits Zydis(R) du segment « technologies orales ». ... Boursier.com Keeping a Sell on Salix Pharma - Mar 7, 2008 Although the approval of granulated Mesalamine and Metoclopramide Zydis, potentially later this year, should help restore confidence in the company, ... Zacks.com Olanzapine (generic) Zyprexa (brand).(YOUR MEDICATION … - Jul 1, 2005 Olanzapine is also available as Zyprexa Zydis orally disintegrating tablets in 5-, 10-, 15- and 20-mg tablets. The tablets are round, yellow and debossed ... Free with registration - Brown University Child and Adolescent... - AccessMyLibrary.com Ranbaxy gathers momentum in novel drug delivery - May 25, 2006 Other companies offering fast-melt technologies include Cardinal Health with its Zydis system, CIMA Labs (OraSOLV, DuraSOLV) and Eurand (AdvaTab). ... In-PharmaTechnologist.com Salix Pharmaceuticals Announces 4Q2007 and FY2007 Financial Results … - Feb 18, 2008 Current development projects include balsalazide tablet, metoclopramide-Zydis([R]),encapsulated mesalamine granules, vapreotide acetate, and rifaximin for ... Free with registration - Business Wire - AccessMyLibrary.com Drugs Linked to Diabetes Risk in Schizophrenics - Jan 5, 2005 Zydis), or risperidone (Risperdal). Participants followed a certain diet to maintain body weight and fasted before having a glucose tolerance test. ... Ivanhoe Broadcast News Salix Pharmaceuticals Announces Submission of Granulated Mesalamine … - Dec 31, 2007 Current development projects include balsalazide tablet, metoclopramide-Zydis®, granulated mesalamine, vapreotide acetate, and rifaximin for additional ... RedOrbit New Therapy For Parkinson's Disease Patients - Sep 6, 2006 ...monoamine oxidase type-B (MAO-B) inhibitor and is the first Parkinson's disease treatment to use a novel delivery system called Zydis(r) Technology, ... Western Queens Gazette Catalent reports profit dip; FDA probes sterile site - May 26, 2008 At the same time, the company's Oral Technologies unit was also a strong performer, with operating profit increasing by $3.2m, led by Zydis, ... OutSourcing-Pharma.com Cardinal sells drug manufacturing biz and doubles Q2 profit - Jan 29, 2007 Among its core offerings, PTS develops and manufactures oral and sterile medication in nearly all dosage forms, and holds patents for Softgel and Zydis ... OutSourcing-Pharma.com NEWLY NAMED CATALENT NOW OPERATES AS INDEPENDENT CO. - Jun 21, 2007 Catalent commercialized softgel capsule technology and Liqui-Gel(R) formulations, created the "fast dissolve" oral tablet category with Zydis(R), ... Free with registration - AsiaPulse News - AccessMyLibrary.com Netherlands Corporate News - Catalent Pharma Solutions maakt vierde … - Sep 18, 2007 The increase was primarily from the Packaging Services segment, particularly within Europe, as well as from continued strong demand for our Zydis(R) ... Netherlands Corporate News - Netherlands Corporate News (persbericht) A partially freeze-dried lyophilization technology for producing fast... - Sep 1, 2007 The new dosage forms had a disintegration time of approximately 4 s compared with about 2 s for a commercial Zydis product. The results are represented in ... Pharmaceutical Technology Magazine Cardinal Health Reports First-Quarter Results. - Oct 27, 2006 Strong earnings growth in the segment's softgel and Zydis(R) fast-dissolve pharmaceutical manufacturing operations and in its pharmaceutical packaging ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Cardinal Health To Sell Segment To The Blackstone … - Jan 24, 2007 Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, and holds patents for softgel and Zydis® ... FierceBiotech Zyprexa (brand).(YOUR MEDICATION INFORMATION)(Drug overview) - Mar 1, 2007 Olanzapine is also available as orally disintegrating tablets (Zyprexa Zydis) in 5-, 10-, 15- and 20-mg tablets. The tablets are round, yellow and debossed ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com Major Depression - Aug 27, 2007 These include haloperidol (Haldol), risperidone (Risperdal), olanzapine (Zyprexa, Zydis), ziprasidone (Geodon) and aripiprazole (Abilify). HealthCentral.com Cardinal Health.(Advertiser Profiles) - Oct 1, 2006 The company's drug delivery technologies include soft gelatin capsules; "Zydis" fast-dissolve dosage form; "EnCirc" "EnVel," and "EnSolv" for oral ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com Salix Pharmaceuticals to Present at Two Investment Conferences During... - Feb 27, 2008 Current development projects include balsalazide tablet, metoclopramide-Zydis([R]),encapsulated mesalamine granules, vapreotide acetate, and rifaximin for ... Free with registration - Business Wire - AccessMyLibrary.com Second-generation antipsychotics offer mixed results; finding the... - Jun 1, 2007 Fazaclo (Alamo) 329.40 Olanzapine--Zyprexa (Lilly) 10-20 mg once 338.10 orally disintegrating-- Zyprexa Zydis 378.90 Quetiapine--Seroquel 125-300 mg bid ... Free with registration - Managed Healthcare Executive - AccessMyLibrary.com Oral strip for generic Zofran - Mar 5, 2007 ...with GlaxoSmithKline's (GSK) Zofran Zydis (ondansetron) orally dissolving tablets for the treatment of chemotherapy related nausea and vomiting. ... In-PharmaTechnologist.com New Parkinson Disease Treatment Approved - Jun 15, 2006 Zelapar has been shown to reduce “offâ€? time an average of 2.2 hours per day using Zydis technology, which allows the tablets to dissolve within seconds in ... Facts and Comparisons Business Update; Company submits response to US FDA approvable … - Jan 31, 2005 Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Cardinal to sell $1.8-billion contract-services unit. - Jan 1, 2007 ...develops and manufactures oral and sterile medication in nearly all dosage forms, and holds patents for softgel and "Zydis" fast-dissolve technologies. ... $9.94 - Pharmaceutical Technology - Alacra Store Business Update; Company submits response to US FDA approvable … - Feb 5, 2005 Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Parkinson Disease: New Insights, New Treatment Options. - Oct 1, 2006 Selegiline, available since 1989, has been reformulated in a new freeze-dried Zydis form, which dissolves rapidly and is absorbed directly through the ... $4.95 - Consultant - ECNext Valeant Parkinson's drug gets FDA approval - Jun 19, 2006 Zelapar, a monoamine oxidase-B (MAO-B) inhibitor, is the first Parkinson's disease treatment to use a novel oral delivery system called Zydis technology, ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Illinois Appellate Court Reports - IN RE LISA P., 381 Ill. App.3d... - Apr 16, 2008 ...psychotropic medication clearly outweighed the Page 1091 possible harm, and she sought to administer Risperdal Consta, lorazepam, Zydis, and quetiapine. ... Pay-Per-View - Illinois Appellate Court Reports - Loislaw PTS division is sold by Cardinal. - Mar 5, 2007 It also holds patents for Zydis fast-dissolving technologies, which are used in many popular prescription and over-the-counter medicines. ... $9.94 - Chain Drug Review - Alacra Store Blackstone to buy Cardinal's PTS unit.(RX/NEWS)(Blackstone Group)( … - Feb 19, 2007 It also holds patents for Zydis fast-dissolving technologies used in many popular prescription and over-the-counter medicines. ... Pay-Per-View - Chain Drug Review - HighBeam Research Cardinal Health Receives Frost & Sullivan Best Bang for the Buck... - May 15, 2006 In the oral dosage form segment, Cardinal Health offers novel proprietary drug delivery techniques through their softgel capsules, Zydis(R) -- a fast ... $4.95 - PR Newswire - ECNext Salix Pharmaceuticals Announces Submission of Granulated Mesalamine … - Dec 31, 2007 Current development projects include balsalazide tablet, metoclopramide-Zydis([R]),granulated mesalamine, vapreotide acetate, and rifaximin for additional ... $4.95 - Business Wire - ECNext Lonnie Ali Champions 'Fight For MORE' Campaign. - Apr 26, 2007 Valeant is the maker of Zelapar(R) (selegiline HCl), the first Parkinson's disease treatment to use a novel oral delivery system called Zydis(R) Technology, ... $4.95 - PR Newswire - ECNext Valeant moves closer to Zelapar approval.(Valeant Pharmaceuticals )( … - Jan 17, 2005 Zelapar is a late-stage candidate under review by the FDA as an oral tablet using patented Zydis fast-dissolving technology, and is being developed as an ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones selegiline Valeant receives US FDA approval for oral disintegrating... - Jun 26, 2006 ZELAPAR was developed using Cardinal Health's ZYDIS technology, which allows tablets to dissolve within seconds in the mouth and deliver more active ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Cardinal Health. - Dec 1, 2005 The company's drug-delivery technologies include soft gelatin capsules, "Zydis" fast-dissolve dosage form; "EnCirc," "EnVel," and "EnSolv" for oral ... $9.94 - Pharmaceutical Technology - Alacra Store Valeant Pharmaceuticals has FDA approval for Zelapar (selegiline HCl)... - Jul 24, 2006 Valeant Pharmaceuticals has FDA approval for Zelapar (selegiline HCl) Orally Disintegrating Tablets. The monoamine oxidase-B inhibitor, using the Zydis oral ... $4.95 - Drug Topics - ECNext Orally disintegrating tablets: products, technologies, and development... - Oct 1, 2005 In contrast, some lyophilization manufacturing processes (e.g., Zydis, Cardinal Health, Dublin, OH) produce fragile freeze-dried tablets and compressed ... $9.94 - Pharmaceutical Technology - Alacra Store Loislaw Federal District Court Opinions - US v. MARTIN (WDNY 8-21- … - Aug 21, 2008 Batavia Detention Center Martin was taking Haldol Deconate: 100 mg. bi-weekly injectable, Cogentin: 2 mg. orally each night by mouth, Zyprexa Zydis:. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw New Parkinson's drug given FDA nod. - Jul 10, 2006 The drug utilizes Zydis technology, which allows tablets to dissolve within seconds in the mouth and deliver more active drug at a lower dose, according to ... $9.94 - Drug Topics - Alacra Store New York Miscellaneous Reports - IN MATTER OF THE APPLICATION … - Nov 6, 2008 ...psychotropic medication, including Zyprexa intramuscular injections up to a maximum doge of 40 mg, with a conversion to Zyprexa Zydis dissolving tables ... Pay-Per-View - New York Miscellaneous Reports - Loislaw Press Release: MultiVu Video Feed: Valeant Pharmaceuticals Receives … - Jun 15, 2006 Zelapar is the first Parkinson's disease treatment to use a novel delivery system called Zydis(R) Technology, which allows the oral tablets to dissolve ... Pay-Per-View - PR Newswire - HighBeam Research Salix Pharmaceuticals Ltd - Company Snapshot - AlacraStore.com - Oct 8, 2008 ...approved by the FDA for this indication. Acquired exclusive, worldwide rights to metoclopramide-Zydis from Wilmington Pharmaceuticals in September 2007. ... Pay-Per-View - co - Alacra Store Valeant Pharmaceuticals has FDA approval for Zelapar (selegiline HCl)... - Jul 24, 2006 The monoamine oxidase-B inhibitor, using the Zydis oral delivery system, provides once-daily adjunct therapy for Parkinson's disease patients who are ... $9.94 - Drug Topics - Alacra Store Senate backs bill limiting sale of pseudoephedrine.(over-the-counter ... - Sep 26, 2005 It also holds patents for Zydis fast-dissolving technologies, which are used in many popular prescription and over-the-counter medicines. ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: Cardinal Health Receives Frost & Sullivan Best Bang... - May 15, 2006 In the oral dosage form segment, Cardinal Health offers novel proprietary drug delivery techniques through their softgel capsules, Zydis(R) -- a fast ... Pay-Per-View - PR Newswire - HighBeam Research PTS division is sold by Cardinal.(Blackstone Group LP acquires … - Mar 5, 2007 It also holds patents for Zydis fast-dissolving technologies, which are used in many popular prescription and over-the-counter medicines. ... Pay-Per-View - Chain Drug Review - HighBeam Research Top 200 drugs used in hospitals in 2006.(Table) - Apr 16, 2007 Keppra 49887033.01 57.58 181 Cozaar 49581063.54 14.90 182 Tygacil 49524794.80 518.76 183 Zyprexa Zydis 49434490.10 13.76 184 Spiriva 49417546.80 68.35 ... $4.95 - Drug Topics - ECNext Neuropharm autism drug enters EMMA trial. - Dec 8, 2008 ...trial will be able to join the 18-month follow-on study, in which all patients will receive the Zydis formulation of fluoxetine used in the SOFIA trial. ... $9.94 - Pharma Marketletter - Alacra Store Cardinal Health. - Jan 1, 2007 The company's drug delivery technologies include soft gelatin capsules; "Zydis" fast-dissolve dosage form; "EnCirc," "EnVel" and "EnSolv" for oral ... $9.94 - Pharmaceutical Technology - Alacra Store |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |